TDACU
Translational Development Acquisition Corp.
Financial Services — Shell Companies
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
None
$12.11
$-0.78 (-6.05%)
Price History
52-Week Range
Sign in to add TDACU to a watchlist or set price alerts.
Fundamentals
| Market Cap | - |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | - |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 69.5 |
| Beta | - |
| SMA 20 | $11.80 |
| SMA 40 | $11.87 |
| 52-Week High | $17.29 |
| 52-Week Low | $10.31 |
| 50-Day Avg | $11.82 |
| 200-Day Avg | $10.79 |
| Avg Volume | 832 |
| Volume | 940 |
Performance Analysis
BULLISHTDACU shows predominantly bullish signals based on its fundamentals and technicals.
~
Trading at 26% of its 52-week range.
+
RSI at 69.5 shows positive momentum.
+
Price is above both the 50-day and 200-day moving averages — strong uptrend.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Aug 01, 2026 04:16 UTC
Back to Screener Export Report